| 3.0 |
18.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.9 |
7.5 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.4 |
4.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.4 |
4.1 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.3 |
5.2 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 1.2 |
2.5 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.2 |
4.8 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.9 |
2.7 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.8 |
2.5 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.6 |
4.9 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.6 |
0.6 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.5 |
2.6 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.5 |
1.5 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.5 |
0.5 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.4 |
1.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.4 |
1.3 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.4 |
5.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.4 |
2.4 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 |
1.2 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.4 |
1.2 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.4 |
1.2 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 |
1.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.4 |
1.1 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.4 |
3.0 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.4 |
12.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.3 |
6.9 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.3 |
8.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.3 |
1.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.3 |
1.9 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 |
0.9 |
GO:0046881 |
sperm ejaculation(GO:0042713) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.3 |
0.9 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 0.3 |
0.9 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
2.5 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.3 |
1.1 |
GO:0097168 |
condensed mesenchymal cell proliferation(GO:0072137) mesenchymal stem cell proliferation(GO:0097168) |
| 0.3 |
0.8 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.3 |
1.6 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
2.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.3 |
0.8 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.2 |
0.9 |
GO:1904749 |
rRNA export from nucleus(GO:0006407) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
0.5 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.2 |
0.9 |
GO:1900623 |
positive regulation of keratinocyte proliferation(GO:0010838) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 |
0.6 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.2 |
0.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.4 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
1.0 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
2.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.4 |
GO:0002192 |
cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
| 0.2 |
1.9 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 |
0.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.2 |
0.5 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
1.0 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) amylase secretion(GO:0036394) |
| 0.2 |
0.7 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.7 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 |
0.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
0.7 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
1.0 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.2 |
0.7 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.2 |
0.8 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.2 |
1.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
0.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.6 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
2.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.7 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.7 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
1.4 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.4 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of cellular pH reduction(GO:0032847) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
0.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.9 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.1 |
0.7 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.4 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.1 |
1.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
1.0 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
3.2 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
0.4 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.8 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.4 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.6 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 |
0.7 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
0.8 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
3.9 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.1 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.1 |
2.6 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.1 |
4.2 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.3 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.1 |
2.1 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
1.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
2.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.5 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.3 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
1.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
0.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
3.8 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.1 |
1.1 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
2.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.4 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.1 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.5 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.1 |
0.2 |
GO:0090135 |
actin filament branching(GO:0090135) negative regulation of phospholipase C activity(GO:1900275) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.7 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
3.1 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.1 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.1 |
1.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
2.3 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
1.6 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
1.3 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.1 |
1.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
1.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
1.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.9 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.2 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.2 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.1 |
0.4 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.2 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 |
0.3 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.6 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
2.0 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.0 |
0.9 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
1.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.2 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.7 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.7 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
1.3 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
1.2 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
2.2 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.3 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
1.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.0 |
0.9 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
1.9 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
1.3 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.7 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
1.4 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
1.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0043122 |
regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
| 0.0 |
1.0 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
1.9 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
2.6 |
GO:0050679 |
positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.0 |
0.5 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
3.9 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.1 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.0 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.3 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.6 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.5 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.2 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
0.4 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.4 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 |
0.5 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.5 |
GO:0030534 |
adult behavior(GO:0030534) |
| 0.0 |
0.4 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.0 |
0.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.0 |
1.2 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.0 |
0.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.4 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.2 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
1.6 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.3 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.1 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.0 |
0.3 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.3 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.0 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
